Lv1
78 积分 2023-07-21 加入
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
8天前
已完结
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
15天前
已关闭
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort
17天前
已关闭
Differential Prognosis and Transplant Strategies in CBF ‐ AML With RUNX1 :: RUNX1T1 Versus CBFβ :: MYH11 Fusions
1个月前
已完结
How I treat secondary acute myeloid leukemia
1个月前
已完结
Study Backs MRD as AML Trial Endpoint
2个月前
已完结
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
2个月前
已完结
NUP98 rearrangements in adult AML patients: Evaluation of clinical implications and identification of novel fusion partners
2个月前
已完结
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
2个月前
已完结
ctDNA detection in cerebrospinal fluid and plasma and mutational concordance with the primary tumor in a multicenter prospective study of patients with glioma
2个月前
已完结
皖公网安备34019202002308
